3BS-31617-52700 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-27
Registered in v-safe
2021-08-27
Dose 1 — Pfizer-BioNTech
2021-08-27
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-08-28
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-08-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-08-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache · Be unable to do your normal daily activities

Adult check-in
2021-09-01
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-09-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fever · Headache

Adult check-in
2021-09-05
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2022-02-25
Survey response — 6 months, dose 1
MedDRA: COVID-19, Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: COVID and migraines

MedDRA releases: 2024-11 · check-in free text available
2022-02-25
Report sent to call center — 6 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-02-28
Call 1 — Could Not Reach Participant
2022-03-03
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-02-25	Unsuccessful

Free text

Release 11 — 6 months, dose 1

2022-02-25

Symptoms: COVID and migraines

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Migraine	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release